Eurobio Scientific (XPAR:ALERS) Shares Outstanding (EOP): 10.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:ALERS Eurobio Scientific XPAR:ALERS
68 GF Score
Price €20.70
GF Value €25.28
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Eurobio Scientific Shares Outstanding (EOP)?

Eurobio Scientific XPAR:ALERS +3.50% 68 Shares Outstanding (EOP) is 10.1 Mil as of Dec. 2025. GuruFocus rates XPAR:ALERS with a GF Score™ of 68/100 and a GF Value™ of €25.28 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Eurobio Scientific's shares outstanding for the quarter that ended in Dec. 2025 was 10.1 Mil.

Eurobio Scientific's quarterly shares outstanding stayed the same from Jun. 2025 (10.1 Mil) to Dec. 2025 (10.1 Mil).

Eurobio Scientific's annual shares outstanding increased from Dec. 2024 (10.0 Mil) to Dec. 2025 (10.1 Mil). It means Eurobio Scientific issued new shares from Dec. 2024 to Dec. 2025 .


Eurobio Scientific  (XPAR:ALERS) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Eurobio Scientific Shares Outstanding (EOP) Related Terms


Eurobio Scientific Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Eurobio Scientific's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurobio Scientific Shares Outstanding (EOP) Chart

Eurobio Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.34 10.22 10.04 10.03 10.07

Eurobio Scientific Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.04 10.04 10.03 10.07 10.07

XPAR:ALERS vs ABT, SYK, MDT: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, Eurobio Scientific's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurobio Scientific Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Eurobio Scientific's Shares Outstanding (EOP) falls into.


XPAR:ALERS
68GF Score
Eurobio Scientific XPAR:ALERS
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurobio Scientific Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 10.1 Mil mean?
Eurobio Scientific (XPAR:ALERS) has a Shares Outstanding (EOP) of 10.1 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Eurobio Scientific and its competitors.
Is Eurobio Scientific's Shares Outstanding (EOP) too high?
Eurobio Scientific's current Shares Outstanding (EOP) is 10.1 Mil. Overall, Eurobio Scientific has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eurobio Scientific's Shares Outstanding (EOP) compare to ABT and SYK?
Eurobio Scientific's Shares Outstanding (EOP) of 10.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Eurobio Scientific and its competitors. Eurobio Scientific's current Shares Outstanding (EOP) is 10.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurobio Scientific stock overvalued right now?
Based on GuruFocus' analysis, Eurobio Scientific (XPAR:ALERS) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.28, compared to a current price of €20.70 — trading 18.1% below its estimated fair value. The current Shares Outstanding (EOP) is 10.1 Mil. Eurobio Scientific's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Eurobio Scientific (XPAR:ALERS), the current Shares Outstanding (EOP) is 10.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurobio Scientific (XPAR:ALERS) Overvalued in 2026?

Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued. The current stock price of €20.70 is trading 18.1% below its estimated GF Value™ of €25.28. GuruFocus considers Eurobio Scientific to be Modestly Undervalued.

Key valuation signals for XPAR:ALERS:

  • Shares Outstanding (EOP): 10.1 Mil
  • GF Value™: €25.28 vs. price of €20.70 (18.1% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the XPAR:ALERS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eurobio Scientific Business Description

Other Exchanges E8TN:Germany
Address 63-65 Boulevard Massena, Paris, FRA, 75013
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
68GF Score

Get the complete analysis for XPAR:ALERS

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.70
Price
€25.28
GF Value